Lab News
“The problem so far has been that the response to PARP inhibitors is not durable... sometimes it lasts six months, sometimes a little longer. But oncologists tell me that almost all patients eventually relapse, so it’s important to find out why.”
-Swarnali Acharyya
Study Suggests Way to Improve Treatment of Hereditary Breast Cancer
August 14, 2024
By Robin Lally
“The combination of axitinib with PARP inhibitors could make resistant cancers more responsive to treatment and may even be effective for patients who don’t respond to PARP inhibitors from the beginning."
-Anup K. Biswas
June 26, 2023
"Developing the first targeted therapy against cancer cachexia"
The Irving Cancer Drug Discovery Program (ICDDP), which debuted in February 2023 as part of the Herbert Irving Comprehensive Cancer Center (HICCC), was established to help faculty accelerate cancer research discoveries and advancements made in their labs to the clinic.
Lung Cancer Research Foundation announces 2022 Scientific Research Grant Awards
December 6, 2022
“I’m truly excited and honored to receive this James B. Dougherty, MD Award for Scientific Merit,” said Dr. Acharyya. “This award will enable us to focus on novel treatments for EGFR-therapy-resistant brain metastasis. I am grateful for the support of the LCRF that will help us take on this challenge.”
- Swarnali Acharyya, PhD
New Research Reveals Promising Drug
Target in Recurrent Lung Cancer
March 2, 2022
"If we unlock the underlying mechanism responsible for relapse in these patients, then we can potentially save a lot more lives suffering from this type of cancer."
- Anup Kumar Biswas, PhD
"We want therapeutic strategies to intervene early, not giving the cancer a chance to re-emerge."
- Swarnali Acharyya, PhD
New Therapeutic Strategies to Treat Metastatic Cancer
February 5, 2021
Presented By
The New York Academy of Sciences
"Cancer research experts shared their work leveraging cell biology, immunology, genomics, microbiology, and more to improve our understanding of metastatic cancer and develop novel treatment strategies."
Systemic Effects of Metastatic Cancer
October 21 - October 22, 2020
Webinar
Presented By
The New York Academy of Sciences
"This symposium aims to deepen our understanding of the complex results of systemic metastatic disease, and inspire the development of effective therapeutic strategies to prevent and treat the systemic outcomes of cancer metastasis."
2019 Schaefer Scholars Announced
May 2, 2019
"The Schaefer Research Scholars Program at VP&S supports research scientists who have distinguished themselves in the science of human physiology and whose proposed research should illuminate the field."
From rock ‘n’ roll to heavy metal
June 28, 2018
Written By
Ulrike Harjes from Nature Reviews Cancer
"Wang, G., Biswas, A. K., Ma, W. et al., who published their results in Nature Medicine, showed that metastatic disease in their models was accompanied by reduction in body weight and loss of muscle tissue."